Organism Engineering Platforms Related News

Biosyntia and FGen to Collaborate on Development of Vitamin Production Strain

April 5, 2017 COPENHAGEN, Denmark & BASEL, Switzerland - Biosyntia ApS, an emerging company in development and production of bio-based natural ingredients, and FGen GmbH, a pioneer in droplet-based high throughput screening, today announced that they join forces in the development [...]

Horizon Discovery enters into R&D and licensing partnership with Amplycell S.A. for bioproduction cell line optimisation

Cambridge, UK and Liege, BE, 8 March 2017 - Horizon Discovery Group plc (LSE: HZD) ("Horizon"), the world leader in the application of gene editing technologies, including the provision of bioproduction cell lines, today announced it has entered into a research and [...]

Heurisko is Supporting the Development of the Bioeconomy Through Directed Evolution in vivo

Heurisko, an international leader in the field of directed evolution, is a small, privately-held biotechnology company founded in 2007 by Philippe Marlière, a scientist and entrepreneur and a co-inventor of the automated evolution technology. Philippe, along with Rupert Mutzel (Institut [...]

By | March 7th, 2017|Industry Providers, News, Organism Engineering Platforms|

Organism Company Ginkgo Bioworks Acquires Synthetic DNA Supplier Gen9

Ginkgo Bioworks, a microorganism design company, has announced today that it has acquired Gen9, one of the leading providers of synthetic DNA. With Gen9’s uniquely efficient DNA synthesis platform in Ginkgo’s tool belt, the self-branded “organism company” will undoubtedly be [...]

Ginkgo Bioworks Acquires Leading Synthetic DNA Provider Gen9

BOSTON, Jan. 20, 2017 /PRNewswire/ -- Ginkgo Bioworks, the organism company, announced today the acquisition of Gen9, a pioneer in the synthesis and assembly of DNA. The acquisition will bring Gen9's unique expertise in assembling pathway-length synthetic DNA into Ginkgo's [...]

Synthetic Genomics (SGI-DNA) Launches Vmax™ Express, a Next-Generation Protein Expression Platform for the Biotech Industry

SAN DIEGO, Jan. 9, 2017 — Synthetic Genomics Inc. announced today that its subsidiary, SGI-DNA, has launched Vmax™ Express, a highly advanced bacterial host organism designed for significant improvement in recombinant protein expression. Compatible with standard plasmids, antibiotics and growth [...]